| 05/05/2026 7:53 AM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/30/2026 3:21 PM | Clearmind Medicine (1892500) Filer | Form F-3 Registration statement for securities of certain foreign private issuers | |
| 04/27/2026 6:45 AM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/21/2026 5:57 AM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/20/2026 4:18 PM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/20/2026 3:05 PM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/15/2026 8:15 AM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/15/2026 6:00 AM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/14/2026 3:01 PM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/14/2026 7:23 AM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/30/2026 11:15 PM | Clearmind Medicine (1892500) Filer | Form EFFECT | |
Get the Latest News and Ratings for CMND and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Clearmind Medicine and its competitors with MarketBeat's FREE daily newsletter.
|
| 03/30/2026 11:15 PM | Clearmind Medicine (1892500) Filer | Form EFFECT | |
| 03/30/2026 8:27 AM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/27/2026 6:40 AM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/25/2026 3:15 PM | Clearmind Medicine (1892500) Filer | Form POS AM | |
| 03/25/2026 3:15 PM | Clearmind Medicine (1892500) Filer | Form POS AM | |
| 03/19/2026 3:01 PM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/17/2026 8:16 AM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/16/2026 10:12 AM | Clearmind Medicine (1892500) Subject L.I.A. Pure Capital Ltd (1749628) Filed by | Form SCHEDULE 13G/A | |
| 03/16/2026 9:17 AM | Capitalink Ltd. (2036836) Filed by Clearmind Medicine (1892500) Subject | Form SCHEDULE 13G/A | |
| 03/13/2026 6:46 AM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/12/2026 3:16 PM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/11/2026 3:01 PM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/10/2026 8:29 AM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/09/2026 3:30 PM | Clearmind Medicine (1892500) Subject Daniel Nissim (2092834) Filed by | Form SCHEDULE 13G/A | |
| 03/04/2026 8:01 AM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/26/2026 11:15 PM | Clearmind Medicine (1892500) Filer | Form EFFECT | |
| 02/17/2026 3:44 PM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/17/2026 3:46 PM | Clearmind Medicine (1892500) Filer | Form F-3 Registration statement for securities of certain foreign private issuers | |
| 02/17/2026 9:48 AM | Clearmind Medicine (1892500) Subject Iroquois Capital Management, LLC (1481867) Filed by | Form SCHEDULE 13G/A | |
| 02/11/2026 3:15 PM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/09/2026 7:19 AM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/06/2026 8:53 AM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/03/2026 7:06 AM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/01/2026 11:15 PM | Clearmind Medicine (1892500) Filer | Form EFFECT | |
| 02/01/2026 11:15 PM | Clearmind Medicine (1892500) Filer | Form EFFECT | |
| 02/01/2026 11:15 PM | Clearmind Medicine (1892500) Filer | Form EFFECT | |
| 01/27/2026 3:15 PM | Clearmind Medicine (1892500) Filer | Form POS AM | |
| 01/27/2026 3:15 PM | Clearmind Medicine (1892500) Filer | Form POS AM | |
| 01/27/2026 3:16 PM | Clearmind Medicine (1892500) Filer | Form POS AM | |
| 01/14/2026 8:00 AM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
|
| 12/31/2025 8:13 AM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/16/2025 7:50 AM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/12/2025 8:00 AM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/12/2025 5:35 AM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/10/2025 3:15 PM | Clearmind Medicine (1892500) Subject L.I.A. Pure Capital Ltd (1749628) Filed by | Form SCHEDULE 13G/A | |
| 12/10/2025 3:15 PM | Capitalink Ltd. (2036836) Filed by Clearmind Medicine (1892500) Subject | Form SCHEDULE 13G/A | |
| 12/10/2025 3:17 PM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/09/2025 11:15 PM | Clearmind Medicine (1892500) Filer | Form EFFECT | |
| 12/05/2025 4:02 PM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/05/2025 3:52 PM | Clearmind Medicine (1892500) Filer | Form F-1/A | |
| 12/05/2025 3:05 PM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/03/2025 5:04 AM | Clearmind Medicine (1892500) Filer | Form 424B5 | |
| 12/03/2025 5:06 AM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/02/2025 7:32 AM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/01/2025 3:15 PM | Clearmind Medicine (1892500) Subject L.I.A. Pure Capital Ltd (1749628) Filed by | Form SCHEDULE 13G | |
| 12/01/2025 3:15 PM | Capitalink Ltd. (2036836) Filed by Clearmind Medicine (1892500) Subject | Form SCHEDULE 13G | |
| 11/28/2025 3:01 PM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/28/2025 3:15 PM | Clearmind Medicine (1892500) Subject Daniel Nissim (2092834) Filed by | Form SCHEDULE 13G | |
| 11/26/2025 3:16 PM | Clearmind Medicine (1892500) Filer | Form F-1 Registration statement for securities of certain foreign private issuers | |
| 11/26/2025 7:48 AM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/26/2025 7:43 AM | Clearmind Medicine (1892500) Filer | Form 424B5 | |
| 11/20/2025 7:08 AM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/19/2025 5:05 AM | Clearmind Medicine (1892500) Filer | Form 424B5 | |
| 11/19/2025 5:09 AM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/18/2025 5:50 AM | Clearmind Medicine (1892500) Subject Iroquois Capital Management, LLC (1481867) Filed by | Form SCHEDULE 13G/A | |
| 11/17/2025 7:00 AM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/17/2025 5:13 AM | Clearmind Medicine (1892500) Filer | Form 424B5 | |
| 11/17/2025 5:15 AM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/13/2025 3:01 PM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/13/2025 6:30 AM | Clearmind Medicine (1892500) Filer | Form 424B5 | |
| 11/13/2025 6:33 AM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/31/2025 7:37 AM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/30/2025 6:56 AM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/27/2025 8:25 AM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/21/2025 6:30 AM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/20/2025 6:45 AM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/30/2025 11:15 PM | Clearmind Medicine (1892500) Filer | Form EFFECT | |
| 09/25/2025 6:56 AM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/21/2025 11:15 PM | Clearmind Medicine (1892500) Filer | Form EFFECT | |
| 09/19/2025 3:16 PM | Clearmind Medicine (1892500) Filer | Form F-1 Registration statement for securities of certain foreign private issuers | |
| 09/19/2025 7:25 AM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/17/2025 3:15 PM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/15/2025 6:06 AM | Clearmind Medicine (1892500) Filer | Form POS AM | |
| 09/11/2025 3:01 PM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 08/07/2025 6:37 AM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 08/05/2025 7:38 AM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/30/2025 7:22 AM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/29/2025 5:20 AM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/15/2025 7:07 AM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/03/2025 12:46 PM | AdvisorShares Trust (1408970) Filed by Clearmind Medicine (1892500) Subject | Form SCHEDULE 13G/A | |
|
| 07/03/2025 12:15 PM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/23/2025 6:56 AM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/19/2025 11:15 PM | Clearmind Medicine (1892500) Filer | Form EFFECT | |
| 06/05/2025 3:57 PM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/12/2025 8:02 AM | Clearmind Medicine (1892500) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |